Autopsy report · NCT00820742

Efficacy, Safety, Tolerability of Pegaptanib Sodium (Macugen) in Filipino Patients With Neovascular Age Related Macular Degeneration.

Cause of deathNo reason given Automatic label, confidence 0.9, unverified. How labels are made.

The sponsor gave no reason.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Sponsor: Pfizer
Sponsor type: Industry
Conditions: Neovascular Age-related Macular Degeneration
Interventions: Macugen
Participants: 0

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.